New Amgen Drug MariTide Shows Promising Weight Loss in Early DataAmgen's experimental obesity drug MariTide shows promise with an average weight loss of up to 20% over a year, pending further trials.
Amgen Drug for Aggressive Type of Lung Cancer Wins Accelerated FDA Approval - MedCity NewsFDA approved a new Amgen drug, Imdelltra, for second-line treatment of small cell lung cancer, offering patients another option.